News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Schor Chen
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/02/2023 |
4
| Schor Chen (President & CEO) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Sold 5,500 shares
@ $1.42, valued at
$7.8k
Bought 5,500 shares
@ $1.42, valued at
$7.8k
Sold 5,500 shares
@ $1.3601, valued at
$7.5k
Bought 5,500 shares
@ $1.3345, valued at
$7.3k
Paid exercise price by delivering 23,208 shares
@ $1.37, valued at
$31.8k
|
|
| 08/16/2023 |
4
| Schor Chen (President & CEO) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Disposed/sold 36,857 options to buy
@ $0
Granted 36,857 options to buy
@ $0
Disposed/sold 872,111 options to buy
@ $16.11, valued at
$14M
Granted 872,111 options to buy
@ $0
Disposed/sold 240,000 options to buy
@ $13.27, valued at
$3.2M
Granted 240,000 options to buy
@ $0
Disposed/sold 421,600 options to buy
@ $16.82, valued at
$7.1M
Granted 421,600 options to buy
@ $0
Disposed/sold 295,000 options to buy
@ $15.52, valued at
$4.6M
Granted 295,000 options to buy
@ $0
Disposed/sold 384,900 options to buy
@ $9.05, valued at
$3.5M
|
|
| 05/25/2023 |
4
| Schor Chen (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 34,000 options to buy
@ $2.5, valued at
$85k
|
|
| 01/26/2023 |
4
| Schor Chen (President & CEO) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Granted 85,500 shares
@ $0
Granted 384,900 options to buy
@ $9.05, valued at
$3.5M
|
|
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2022 |
4
| Schor Chen (President & CEO) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Paid exercise price by delivering 21,288 shares
@ $14.22, valued at
$302.7k
|
|
| 09/16/2022 |
4
| Schor Chen (President & CEO) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Sold 952 shares
@ $18, valued at
$17.1k
|
|
| 09/13/2022 |
4
| Schor Chen (President & CEO) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Sold 8,094 shares
@ $16.5062, valued at
$133.6k
Sold 66,747 shares
@ $16.7694, valued at
$1.1M
Sold 200 shares
@ $18, valued at
$3.6k
Sold 3,371 shares
@ $18.0105, valued at
$60.7k
|
|
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
4
| Schor Chen (President & CEO) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Granted 48,000 shares
@ $0
Paid exercise price by delivering 21,288 shares
@ $11.69, valued at
$248.9k
|
|
| 01/11/2022 |
4
| Schor Chen (President & CEO) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Granted 295,000 options to buy
@ $15.52, valued at
$4.6M
|
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
4
| Schor Chen (President & CEO) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Sold 4,426 shares
@ $13.8957, valued at
$61.5k
Sold 3,058 shares
@ $14.7006, valued at
$45k
Sold 5,312 shares
@ $13.8957, valued at
$73.8k
Sold 3,670 shares
@ $14.7006, valued at
$54k
|
|
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Schor Chen (President and CEO) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Sold 3,582 shares
@ $12.3, valued at
$44.1k
Sold 2,984 shares
@ $12.3, valued at
$36.7k
Sold 5,400 shares
@ $13.22, valued at
$71.4k
Sold 4,500 shares
@ $13.22, valued at
$59.5k
|
|
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2020 |
4
| Schor Chen (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 32,800 options to buy
@ $14.75, valued at
$483.8k
|
|
| 10/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2020 |
4
| Schor Chen (President and CEO) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Granted 872,111 options to buy
@ $16.11, valued at
$14M
|
|
| 12/06/2019 |
4
| Schor Chen (President and CEO) has filed a Form 4 on resTORbio, Inc.|
Txns:
| Granted 344,000 shares
@ $0
Granted 258,000 options to buy
@ $1.27, valued at
$327.7k
|
|
| 02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2018 |
4
| Schor Chen (Director) has filed a Form 4 on BRAINSTORM CELL THERAPEUTICS INC.|
Txns:
| Gifted 121,558 shares
@ $0
Gifted 121,558 shares
@ $0 |
|
| 12/17/2018 |
4
| Schor Chen (See Remarks) has filed a Form 4 on resTORbio, Inc.|
Txns:
| Gifted 943,000 shares
@ $0
Gifted 593,363 shares
@ $0
Gifted 25,000 shares
@ $0
Gifted 643,000 shares
@ $0
Gifted 25,000 shares
@ $0
Gifted 6,000 shares
@ $0 |
|
|
|
|